Literature DB >> 20439633

Active surveillance for early-stage prostate cancer: defining the triggers for intervention.

Jared M Whitson, Peter R Carroll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20439633     DOI： 10.1200/JCO.2010.28.5817

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Active surveillance for low-risk prostate cancer: diversity of practice across Europe.

Authors:  A Azmi; R A Dillon; S Borghesi; M Dunne; R E Power; L Marignol; B D P O'Neill
Journal:  Ir J Med Sci       Date:  2014-03-21       Impact factor: 1.568

2.  Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Authors:  Matthew R Cooperberg; Janet E Cowan; Joan F Hilton; Adam C Reese; Harras B Zaid; Sima P Porten; Katsuto Shinohara; Maxwell V Meng; Kirsten L Greene; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

3.  Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity.

Authors:  A M Algotar; P A Thompson; J Ranger-Moore; M S Stratton; C H Hsu; F R Ahmann; R B Nagle; S P Stratton
Journal:  Intern Med J       Date:  2012-04       Impact factor: 2.048

Review 4.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

5.  Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Authors:  Scott P Kelly; Stephen K Van Den Eeden; Richard M Hoffman; David S Aaronson; Tania Lobo; George Luta; Amethyst D Leimpter; Jun Shan; Arnold L Potosky; Kathryn L Taylor
Journal:  J Urol       Date:  2016-04-14       Impact factor: 7.450

Review 6.  Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.

Authors:  Sergey Reva; Alexander Nosov; Roman Novikov; Sergey Petrov
Journal:  Int Sch Res Notices       Date:  2014-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.